RDW to Platlet Count Ratio in CKD Patients
Red Blood Cell Distribution Width to Platelet Count Ratio as a Predictor of Cardiovascular Complications in CKD Patients
1 other identifier
observational
100
0 countries
N/A
Brief Summary
The aim of the study is to determine Red blood cell distribution width to platelet count ratio as a predictor of cardiovascular complications in CKD patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2023
CompletedFirst Posted
Study publicly available on registry
March 6, 2023
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2024
CompletedMarch 16, 2023
March 1, 2023
11 months
February 22, 2023
March 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison of results of RDW to platlet ratio in CKD patients
Calculate RDW to platlet ratio for CKD patints with or without cardiovascular complications and compare the results
1 year
Study Arms (2)
1-CKD patients without cardiovascular complications
2-CKD patients with cardiovascular complications
Interventions
RDW to platlet ratio will be measured for all patients and results will be compared between groups
Eligibility Criteria
CKD Patients and patients receive dialysis admitted to Sohag University hospital at period of admission 18 years or older.
You may qualify if:
- CKD Patients and patients receive dialysis \>18 years old
You may not qualify if:
- Serious complications of any other organs
- patients who had previously undergone kidney transplantation .
- CKD patients with history of previous CVD
- patients with an infection, blood transfusion or receiving immunosuppressive drugs, as this may have affected the inflammatory response within the 3 months
- patients who were pregnant
- patients with chronic hematological disease
- patient\<18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Related Publications (1)
Jankowski J, Floege J, Fliser D, Bohm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.
PMID: 33720773BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
February 22, 2023
First Posted
March 6, 2023
Study Start
April 1, 2023
Primary Completion
February 22, 2024
Study Completion
March 22, 2024
Last Updated
March 16, 2023
Record last verified: 2023-03